FR2567124B1 - Nouvelle forme d cristalline, stable, anhydre du chlorhydrate de prazosine et nouveau procede pour la preparation de cette forme d cristalline - Google Patents

Nouvelle forme d cristalline, stable, anhydre du chlorhydrate de prazosine et nouveau procede pour la preparation de cette forme d cristalline

Info

Publication number
FR2567124B1
FR2567124B1 FR8416401A FR8416401A FR2567124B1 FR 2567124 B1 FR2567124 B1 FR 2567124B1 FR 8416401 A FR8416401 A FR 8416401A FR 8416401 A FR8416401 A FR 8416401A FR 2567124 B1 FR2567124 B1 FR 2567124B1
Authority
FR
France
Prior art keywords
crystalline
novel
stable
preparation
new process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8416401A
Other languages
English (en)
French (fr)
Other versions
FR2567124A1 (fr
Inventor
Stig Olof Engelbert Lindholm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Fermion Oy
Original Assignee
Orion Yhtyma Fermion Oy
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Fermion Oy, Orion Yhtyma Oy filed Critical Orion Yhtyma Fermion Oy
Publication of FR2567124A1 publication Critical patent/FR2567124A1/fr
Application granted granted Critical
Publication of FR2567124B1 publication Critical patent/FR2567124B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR8416401A 1984-06-25 1984-10-26 Nouvelle forme d cristalline, stable, anhydre du chlorhydrate de prazosine et nouveau procede pour la preparation de cette forme d cristalline Expired - Lifetime FR2567124B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI842544A FI79107C (fi) 1984-06-25 1984-06-25 Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.

Publications (2)

Publication Number Publication Date
FR2567124A1 FR2567124A1 (fr) 1986-01-10
FR2567124B1 true FR2567124B1 (fr) 1990-09-21

Family

ID=8519293

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8416401A Expired - Lifetime FR2567124B1 (fr) 1984-06-25 1984-10-26 Nouvelle forme d cristalline, stable, anhydre du chlorhydrate de prazosine et nouveau procede pour la preparation de cette forme d cristalline

Country Status (17)

Country Link
US (2) US4739055A (cg-RX-API-DMAC7.html)
JP (1) JPS6115881A (cg-RX-API-DMAC7.html)
AT (1) AT389117B (cg-RX-API-DMAC7.html)
AU (1) AU566814B2 (cg-RX-API-DMAC7.html)
BE (1) BE900925A (cg-RX-API-DMAC7.html)
CH (1) CH661045A5 (cg-RX-API-DMAC7.html)
DE (1) DE3429415A1 (cg-RX-API-DMAC7.html)
FI (1) FI79107C (cg-RX-API-DMAC7.html)
FR (1) FR2567124B1 (cg-RX-API-DMAC7.html)
GB (1) GB2160861B (cg-RX-API-DMAC7.html)
IL (1) IL73267A (cg-RX-API-DMAC7.html)
IT (1) IT1224142B (cg-RX-API-DMAC7.html)
LU (1) LU85616A1 (cg-RX-API-DMAC7.html)
NL (1) NL8403250A (cg-RX-API-DMAC7.html)
NZ (1) NZ209962A (cg-RX-API-DMAC7.html)
PT (1) PT79411B (cg-RX-API-DMAC7.html)
ZA (1) ZA85910B (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683760D1 (de) * 1986-03-21 1992-03-12 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
JP2756846B2 (ja) * 1989-12-28 1998-05-25 住化ファインケム株式会社 無水のε型結晶体２―〔４―（２―フロイル）ピペラジン―１―イル〕―４―アミノ―６，７―ジメトキシキナゾリン塩酸塩及びその製造方法
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
DK1757606T3 (da) * 2001-02-24 2009-09-07 Boehringer Ingelheim Pharma Anvendelse af xanthinderivater som l gemidler samt fremgangsm de til deres fremstilling
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
JP5323684B2 (ja) * 2006-05-04 2013-10-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 多形体
PE20080251A1 (es) * 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
AU2008290582B2 (en) * 2007-08-17 2014-08-14 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
EP2326326B1 (en) * 2008-08-15 2019-10-09 Boehringer Ingelheim International GmbH Dpp-4 inhibitors for use for the treatment of wound healing in diabetic patients
JP2012502081A (ja) 2008-09-10 2012-01-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病及び関連症状の治療のための組み合わせ治療
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
TWI508965B (zh) 2008-12-23 2015-11-21 Boehringer Ingelheim Int 有機化合物的鹽形式
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
KR20190071840A (ko) 2009-11-27 2019-06-24 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
MX366325B (es) 2010-05-05 2019-07-05 Boehringer Ingelheim Int Terapia de combinacion.
CA2803504C (en) 2010-06-24 2022-08-30 Boehringer Ingelheim International Gmbh A combination for diabetes therapy comprising linagliptin and a long-acting insulin
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
KR101985384B1 (ko) 2011-07-15 2019-06-03 베링거 인겔하임 인터내셔날 게엠베하 치환된 퀴나졸린, 이의 제조 및 약제학적 조성물에서의 이의 용도
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
JP6218811B2 (ja) 2012-05-14 2017-10-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｓｉｒｓ及び／又は敗血症の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
EP2849755A1 (en) 2012-05-14 2015-03-25 Boehringer Ingelheim International GmbH A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
BR112018072401A2 (pt) 2016-06-10 2019-02-19 Boehringer Ingelheim International Gmbh combinações de linagliptina e metformina

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2969375A (en) * 1961-01-24 Certification of correction
DE156532C (cg-RX-API-DMAC7.html) *
BE427505A (cg-RX-API-DMAC7.html) * 1937-05-25
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3433788A (en) * 1966-04-27 1969-03-18 Union Carbide Corp Process for recovery of amines from aqueous solutions by solvent treatment and distillation
US3421983A (en) * 1967-03-07 1969-01-14 Lummus Co Azeotropic distillation of aqueous toluene diamine
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3743672A (en) * 1970-05-27 1973-07-03 Halcon International Inc Separation of water in alkylene glycol mono and diester purification by azeotropic distillation
GB1308718A (en) * 1970-07-01 1973-03-07 Sir Soc Italiana Resine Spa Method of separating vinyl acetate from liquid mixtures
IT956765B (it) * 1972-06-22 1973-10-10 Montedison Spa Procedimento per la purificazione di 1 3 diossolano
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
FI64367C (fi) * 1980-02-26 1986-08-05 Orion Yhtymae Oy Foerfarande foer framstaellning av alfa-form av prazosinhydroklorid

Also Published As

Publication number Publication date
GB8424999D0 (en) 1984-11-07
CH661045A5 (de) 1987-06-30
NL8403250A (nl) 1986-01-16
FI842544A0 (fi) 1984-06-25
AU3451084A (en) 1986-01-02
FI79107B (fi) 1989-07-31
BE900925A (fr) 1985-02-15
FI79107C (fi) 1989-11-10
AU566814B2 (en) 1987-10-29
LU85616A1 (fr) 1985-06-04
ZA85910B (en) 1985-09-25
IT8423292A0 (it) 1984-10-24
IL73267A (en) 1988-06-30
IT1224142B (it) 1990-09-26
JPS6115881A (ja) 1986-01-23
US4873330A (en) 1989-10-10
AT389117B (de) 1989-10-25
ATA344184A (de) 1989-03-15
IL73267A0 (en) 1985-01-31
PT79411B (en) 1986-09-15
US4739055A (en) 1988-04-19
FI842544L (fi) 1985-12-26
FR2567124A1 (fr) 1986-01-10
PT79411A (en) 1984-11-01
DE3429415A1 (de) 1986-01-02
DE3429415C2 (cg-RX-API-DMAC7.html) 1990-05-03
GB2160861B (en) 1987-11-18
JPH0481993B2 (cg-RX-API-DMAC7.html) 1992-12-25
NZ209962A (en) 1987-06-30
GB2160861A (en) 1986-01-02

Similar Documents

Publication Publication Date Title
FR2567124B1 (fr) Nouvelle forme d cristalline, stable, anhydre du chlorhydrate de prazosine et nouveau procede pour la preparation de cette forme d cristalline
RO76487A (ro) Procedeu pentru prepararea unor derivati acilati ai anilinei
RO90622A (ro) Procedeu pentru prepararea unor derivati de piperidina
FR2553792B1 (fr) Nouvelle cellule d'electrolyse et procede pour l'electrolyse des halogenures
BE884583A (fr) Nouvelle cellule d'electrolyse et procede pour l'electrolyse des halogenures
FR2572094B1 (fr) Procede pour la preparation continue de l'ethanol
RO73095A (ro) Procedeu pentru prepararea formei cristaline & a hidroclorurii de 2-(4-(2-furoil)-piperazin-l-il)-4-amino-6,7-dimetoxichinazolina
FR2568570B1 (fr) Procede pour la fabrication de derives 3-substitues du 1-amino-2-hydroxypropane
RO91350A (ro) Procedeu pentru prepararea carbamatului de celuloza
FR2550788B1 (fr) Nouveau procede de preparation d'a-6-desoxytetracyclines
RO96413A (ro) Procedeu pentru prepararea unor derivati de tiadiazol
RO91422A (ro) Procedeu pentru prepararea unor derivati de 1,3-oxazolidin-2-ona
RO79164A (ro) Procedeu pentru prepararea unor derivati de 1-alil-triazol
FR2515651B1 (fr) Procede de preparation de derives de l'eburnamonine et nouvelles quinolizines utilisees comme produits de depart de cette preparation
RO92777A (ro) Procedeu pentru prepararea unor derivati de tiazol
BE869140A (fr) Procede pour la preparation d'amides alpha-cetocarboxyliques n-substitues et produits obtenus
RO92966A (ro) Procedeu pentru prepararea unor pirazoline
FR2644161B1 (fr) Procede de preparation d'amides n-arylsubstitues
FR2618779B1 (fr) Nouveau procede de preparation des 1,2,4-triazol-3-ones
RO90233A (ro) Procedeu pentru prepararea unor derivati de 1,2,4(tia)-diazolin-3-ona
FR2574792B1 (fr) Procede pour la preparation de derives de pyrrolidine
FR2615853B1 (fr) Nouveau procede pour la preparation de derives de la piperazine pharmacologiquement actifs, derives et nouveaux intermediaires obtenus
FR2518989B1 (fr) Forme cristalline l de la bestatine et procede pour sa preparation
RO94455A (ro) Procedeu pentru prepararea unor derivati de 2-oxindol-1-carboxamida
YU173585A (en) Process for obtaining derivatives of 3,4-diazole

Legal Events

Date Code Title Description
ST Notification of lapse